Our studies directly assess the effect of tirzepatide on glucagon secretion, but clinical trials with tirzepatide have reported reductions in both fasting glucagon and the glucagon response from a mixed-meal challenge 17
Though the risk of side effects are low with microdoses, some patients may experience mild side effects like nausea, vomiting, upset stomach, diarrhea, or similar gastrointestinal side effects after the initial doses
If were working on eating disorder treatment focusing primarily on just weight loss, it does kind of go against the ethos of what were working toward. Ihlenfeld added that some small studies have found GLP-1s may help reduce binge eating behaviors
7 9 This conclusion arises from both epidemiologic studies and the fact that embryologic events leading to cleft lip/palate and cleft palate occur at somewhat different times (37 weeks versus 512 weeks)
Regular review ensures treatment remains appropriate and effective, with adjustments made according to symptom response and individual needs
, IL-1, IL-6, and IL-7) and chemokines ( i.e